457 Multicenter phase II study of sequential hormonotherapy with Anastrozol/Exemestane (ARIM-AROM) in metastatic breast disease. Preliminary data of Goim 2107 study
Ejc Supplements（2003）
Key words
phase ii study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined